Daily Maverick on MSN4d
New chronic kidney disease treatments show promise, but are expensive and inaccessibleWhile the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...
Patients with CKD were older, more likely to be Hispanics, to have less education, New York Heart Association class III, elevated systolic blood pressure, and diabetes. There was no statistical ...
With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...
The CKD treatment market is segmented by drug class, including Erythropoietin Stimulating Agents (ESAs), Angiotensin-Converting Enzyme Inhibitors (ACE-Is), Angiotensin Receptor Blockers (ARBs ...
Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure ...
Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback